Page last updated: 2024-09-02

arginyl-glycyl-aspartyl-serine and Cancer of Prostate

arginyl-glycyl-aspartyl-serine has been researched along with Cancer of Prostate in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Brite, KH; Chatterjee, S; Matsumura, A1

Other Studies

1 other study(ies) available for arginyl-glycyl-aspartyl-serine and Cancer of Prostate

ArticleYear
Induction of apoptosis of integrin-expressing human prostate cancer cells by cyclic Arg-Gly-Asp peptides.
    Clinical cancer research : an official journal of the American Association for Cancer Research, 2001, Volume: 7, Issue:10

    Topics: Antineoplastic Agents; Apoptosis; Cell Line; Dose-Response Relationship, Drug; Fluorescent Antibody Technique; Focal Adhesion Kinase 1; Focal Adhesion Protein-Tyrosine Kinases; Humans; Integrins; Male; Oligopeptides; Peptides, Cyclic; Phosphorylation; Poly(ADP-ribose) Polymerases; Prostatic Neoplasms; Protein Serine-Threonine Kinases; Protein-Tyrosine Kinases; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-akt; Receptors, Vitronectin; Tumor Cells, Cultured

2001